Skip to content

Ascend

Business Overview

Ascend is set to become a state-of-the-art oral solid dosage (OSD) manufacturing hub, poised to capitalize on Ethiopia’s pharmaceutical market.
The plant has already secured a temporary license from the Ethiopian Food and Drug Administration to produce stability batches, a crucial step towards obtaining final GMP certification.

Financial

Geography
Africa
Investment
100% Sale to Strategic Buyer
Industry
Pharmacuetical Manufacturing
Financials
Revenue
EBIDTA
Mar-2024
N/A
N/A
March 2025 Projected
N/A
N/A
2026 Projected
$ 6 mn
N/A

Listing Inquiry